Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gilbert

Showing results (1291-1300 of 1,457) with videos related to

Pageof 146
Sort By:
Oncotarget|June 18, 2020
Efficacy of osimertinib against EGFRvIII+ glioblastomaGustavo Chagoya, Shawn G Kwatra, Cory W Nanni, et al.
Genomics|November 24, 1999
Genetic studies of autistic disorder and chromosome 7A Ashley-Koch, C M Wolpert, M M Menold, et al.
Human Molecular Genetics|August 25, 2000
Myotilin is mutated in limb girdle muscular dystrophy 1AM A Hauser, S K Horrigan, P Salmikangas, et al.
Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.
Journal of Neuro-Oncology|June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningiomaAndrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.
Acta Neuropathologica|February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.
Neuro-Oncology|February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscapeDavid A Reardon, Evanthia Galanis, John F DeGroot, et al.
NEJM Evidence|April 30, 2025
Mepolizumab for COPD with Eosinophilic Phenotype following HospitalizationCara A Flynn, Hamish J C McAuley, Omer Elneima, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001Vinai Gondi, Snehal Deshmukh, Paul D Brown, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Pageof 146

Showing results (1291-1300 of 1,457) with videos related to

Sort By:
Pageof 146
Oncotarget|June 18, 2020
Efficacy of osimertinib against EGFRvIII+ glioblastomaGustavo Chagoya, Shawn G Kwatra, Cory W Nanni, et al.
Genomics|November 24, 1999
Genetic studies of autistic disorder and chromosome 7A Ashley-Koch, C M Wolpert, M M Menold, et al.
Human Molecular Genetics|August 25, 2000
Myotilin is mutated in limb girdle muscular dystrophy 1AM A Hauser, S K Horrigan, P Salmikangas, et al.
Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.
Journal of Neuro-Oncology|June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningiomaAndrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.
Acta Neuropathologica|February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.
Neuro-Oncology|February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscapeDavid A Reardon, Evanthia Galanis, John F DeGroot, et al.
NEJM Evidence|April 30, 2025
Mepolizumab for COPD with Eosinophilic Phenotype following HospitalizationCara A Flynn, Hamish J C McAuley, Omer Elneima, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001Vinai Gondi, Snehal Deshmukh, Paul D Brown, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Pageof 146